| Cvs Pharmacy #16054 | |
| 4201 W Division St, Suite A124, Saint Cloud, Minnesota 56301 | |
| (320) 253-4646 |
| Name | Cvs Pharmacy #16054 |
|---|---|
| Organization Name | Grand St Paul Cvs Llc |
| Location | 4201 W Division St, Suite A124, Saint Cloud, Minnesota 56301 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (320) 253-4646 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Among patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease, those who received antibiotics in the first 2 hospital days had improved outcomes, such as a lower likelihood of mechanical ventilation and fewer readmissions, compared to patients who received antibiotics later or not at all, according to a study in the May 26 issue of JAMA.
The prion diseases were originally discovered by Dr Gajdusek and Dr Gibbs. The first disease discovered was Kuru, which was affecting native tribes in the Papua New Guinea highlands in the 1950s.
At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.
BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.
› Verified 6 days ago
| NPI Number | 1689696361 |
| Organization Name | GRAND ST PAUL CVS LLC |
| Doing Business As | CVS PHARMACY #16054 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 4201 W Division St, Saint Cloud, MN 56301 |
| Phone Number | 320-253-4646 |
News Archive
Among patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease, those who received antibiotics in the first 2 hospital days had improved outcomes, such as a lower likelihood of mechanical ventilation and fewer readmissions, compared to patients who received antibiotics later or not at all, according to a study in the May 26 issue of JAMA.
The prion diseases were originally discovered by Dr Gajdusek and Dr Gibbs. The first disease discovered was Kuru, which was affecting native tribes in the Papua New Guinea highlands in the 1950s.
At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.
BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.
› Verified 6 days ago
News Archive
Among patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease, those who received antibiotics in the first 2 hospital days had improved outcomes, such as a lower likelihood of mechanical ventilation and fewer readmissions, compared to patients who received antibiotics later or not at all, according to a study in the May 26 issue of JAMA.
The prion diseases were originally discovered by Dr Gajdusek and Dr Gibbs. The first disease discovered was Kuru, which was affecting native tribes in the Papua New Guinea highlands in the 1950s.
At the 2013 American Society of Hematology meeting in Dec. 2013, James Kochenderfer, M.D., investigator in the Experimental Transplantation and Immunology Branch, NCI, presented findings from two clinical trials evaluating the use of genetically modified immune system T cells as cancer therapy.
BHR Pharma, LLC (BHR) announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its proprietary BHR-100 intravenous progesterone infusion product.
› Verified 6 days ago
Centracare Clinic Type: Medicare Supplier Location: 1200 6th Ave N, Saint Cloud, Minnesota 56303 Phone: (320) 252-5131 | |
Cvs Pharmacy #16352 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 125 Lincoln Ave Se, Saint Cloud, Minnesota 56304 Phone: (320) 654-0712 | |
Cvs Pharmacy #16054 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4201 W Division St, Suite A124, Saint Cloud, Minnesota 56301 Phone: (320) 253-4646 | |
Lincare Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3900 Roosevelt Rd, Saint Cloud, Minnesota 56301 Phone: (320) 654-1747 | |
Wal-mart Pharmacy 10-1633 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 21 County Road 120, Saint Cloud, Minnesota 56303 Phone: (320) 259-6363 |